CanadaIXCHIQ (chikungunya vaccine, live, attenuated), powder for solution for intramuscular injection, is the subject of a Health Canada safety communication. Post-marketing data suggest individuals 65 years of age and older who are medically frail with multiple chronic medical conditions may be at increased risk of serious and life‑threatening adverse reactions following recent vaccination; see Key Messages below.
How to identify it
IXCHIQ (chikungunya vaccine, live, attenuated), powder for solution for intramuscular injection.
The hazard
Post-marketing data suggest that individuals 65 years of age and older who are medically frail with multiple chronic medical conditions may be at an increased risk of serious and life-threatening adverse reactions following recent vaccination with IXCHIQ.
What to do
See Key Messages below
Where it was sold
National
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)